Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.
about
Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell functionCandida infections of the genitourinary tract.Recurrent vulvovaginal candidosis among young women in south eastern Nigeria: the role of lifestyle and health-care practices.Humoral immune responses to Candida albicans complement receptor 3-related protein in the atopic subjects with vulvovaginal candidiasis. Novel sensitive marker for Candida infection.
P2860
Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.
@ast
Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.
@en
type
label
Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.
@ast
Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.
@en
prefLabel
Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.
@ast
Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.
@en
P2093
P2860
P356
P1476
Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.
@en
P2093
P2860
P304
P356
10.1136/STI.2002.003491
P577
2004-06-01T00:00:00Z